Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BYSIthis companyBeyondSpring Inc.	$0.62	-8.15×	-2.05×	0×	-6.84×	-78.1%	0.0%	0.0%	0.0%	24.8%	-70.6%	-30.5%	-0.01×	0.87×	0×	1.54×	0.0%	1	-41.21	2	C+
ALXOALX Oncology Holdings Inc.	$1.22	-0.59×	2.33×	0×	-0.5×	-90.6%	0.0%	0.0%	0.0%	-391.4%	-262.0%	-139.1%	0.2×	0.11×	-64.93×	2.07×	0.0%	2	-2.66	2	C
ATYRaTyr Pharma, Inc.	$7.26	-0.98×	1.08×	383.2×	-1.02×	-128.4%	-717.4%	-40856.3%	-39009.5%	-109.8%	-96.5%	-85.2%	0.18×	-0.02×	0×	5.3×	0.0%	2	-14.23	2	C
BMEABiomea Fusion, Inc.	$0.60	-1.05×	2.19×	0×	-0.17×	48.4%	0.0%	0.0%	0.0%	-209.1%	-166.2%	-108.7%	0.05×	0.9×	0×	5.23×	0.0%	0	-18.95	2	C+
CAMPCAMP4 Therapeutics Corporation	$4.34	-2.31×	3.9×	53.24×	-1.56×	-1164.1%	53.1%	-1488.3%	-2298.5%	-168.5%	-50.8%	-16.0%	0.04×	2.13×	0×	7.35×	0.0%	1	-5.32	2	C
DTILPrecision BioSciences, Inc.	$10.73	-1.17×	0.58×	1.56×	0.68×	-257.3%	100.0%	-152.2%	-133.4%	-49.6%	-35.5%	-123.6%	0.31×	1.93×	-36.67×	13.32×	0.0%	3	-4.84	1	C-
Peer median	—	-1.05×	2.19×	1.56×	-0.5×	-128.4%	0.0%	-152.2%	-133.4%	-168.5%	-96.5%	-108.7%	0.18×	0.9×	0×	5.3×	0.0%	2	-5.32	2	—